Make an Appointment
Talk to DoctorOverview
Renal cell carcinoma (RCC) is the most common form of kidney cancer. It develops when abnormal cells in the tiny filtering tubes within the kidneys begin to multiply uncontrollably, eventually forming a tumor. Because this disease is typically asymptomatic (early), many patients do not experience warning signs until the tumor has grown or affected nearby organs. As a serious condition that is especially common in men aged 60 to 80, understanding renal cell carcinoma is essential for early detection, which vastly improves the chances of successful treatment and long-term recovery.
Types
- Clear Cell Renal Cell Carcinoma (ccRCC): This is the most prevalent form, making up roughly 85% of all renal cell carcinoma cases. It gets its name because the tumor cells look pale or clear when examined under a microscope.
- Papillary Renal Cell Carcinoma: Accounting for about 10% to 15% of cases, this type is characterized by small, finger-like projections—called papillae—growing on the surface of the tumor.
- Chromophobe Renal Cell Carcinoma: A less common type representing 5% to 10% of diagnoses. Like clear cell RCC, the cells appear pale, but they are generally larger in size.
- Unclassified Renal Cell Carcinoma: Up to 6% of kidney tumors do not fit into the standard categories. Medical researchers are continuously studying these cells’ DNA to classify and treat them more effectively.
Symptoms
Renal cell carcinoma symptoms usually become apparent only as the tumor grows and presses on surrounding tissues. When they do appear, symptoms can include:
- Blood in Urine (Hematuria): A hallmark sign of kidney cancer, where the urine may appear pink, rusty, or dark red.
- Flank Pain: A persistent, lingering pain or ache on the side of your body, usually located between the ribs and the hips.
- Abdominal Mass: A firm, palpable lump or swelling felt in the abdomen, lower back, or flank area.
- Unexplained Weight Loss: Dropping pounds rapidly without any changes to your diet or exercise routine.
- Systemic Signs: These can include persistent fevers (not linked to a cold), night sweats, and severe fatigue or shortness of breath resulting from anemia.
Causes
While medical professionals are still studying the exact triggers, the development of renal cell carcinoma generally follows a specific process:
- Abnormal changes or mutations occur in the DNA of cells lining the kidney’s tiny tubules.
- These mutated cells begin to grow and divide rapidly, outliving healthy cells.
- The accumulating abnormal cells cluster together to form a solid mass or tumor within the kidney.
Risk Factors
- Smoking: Tobacco use heavily increases the risk of kidney cancer, with the risk scaling up the more a person smokes.
- Obesity: Having a high body mass index (BMI) can alter hormones in the body that may contribute to cancer development.
- High Blood Pressure (Hypertension): A history of uncontrolled high blood pressure is closely linked to a higher risk of developing RCC.
- Chronic Kidney Disease: Patients with long-term kidney issues, especially those requiring prolonged dialysis, face a higher risk.
- Workplace Toxins: Long-term exposure to certain cancer-causing agents, such as asbestos and cadmium.
- Genetics: A family history of kidney cancer or inherited genetic syndromes, like von Hippel-Lindau (VHL) disease.
- Medication Use: Prolonged, heavy use of certain pain relievers, including NSAIDs and acetaminophen.
Diagnosis
Since the early stages rarely present symptoms, renal cell carcinoma is often found incidentally during imaging for other medical concerns. To officially diagnose and stage the cancer, doctors utilize:
- Ultrasound: This non-invasive test uses high-frequency sound waves to map the kidneys. It is highly effective at determining whether a kidney mass is a harmless fluid-filled cyst or a solid tumor indicative of cancer.
- Computed Tomography (CT) Scan: A CT scan combines multiple X-rays to produce detailed, cross-sectional views of the body. Doctors typically use an intravenous contrast dye that travels to the kidneys, highlighting the tumor’s exact size, shape, and location.
- Magnetic Resonance Imaging (MRI): Using strong magnets and radio waves, an MRI provides high-resolution images of soft tissues. It is an excellent alternative for patients who cannot tolerate CT scan contrast dye.
- Surgical Pathology: Interestingly, traditional needle biopsies are rarely used for renal cell carcinoma due to the risk of damaging the kidney. Instead, doctors usually diagnose the specific cancer type by examining the tumor tissue under a microscope after it has been surgically removed.
Treatment
Treatment for renal cell carcinoma is tailored to the patient’s overall health and the stage of the cancer. Standard treatments include:
- Surgery (Nephrectomy): The primary treatment for localized kidney cancer. A radical nephrectomy removes the entire affected kidney and surrounding tissues, while a partial nephrectomy carefully removes only the tumor, preserving the rest of the healthy kidney function.
- Ablation Therapy: For patients who are not candidates for surgery, doctors can use extreme temperatures to destroy the tumor. Cryotherapy uses freezing gas to kill the cancer cells, while radiofrequency ablation uses electrical currents to burn them away.
- Targeted Therapy: Often used for advanced renal cell carcinoma, these specialized drugs block the specific signals and blood vessels that tumors need to survive and grow, effectively starving the cancer cells.
- Immunotherapy: This systemic treatment involves medications that stimulate and strengthen the patient’s own immune system, training it to recognize and attack cancer cells throughout the body.
Frequently Asked Questions
1. Is renal cell carcinoma curable?
Yes, it can be curable, especially when detected early. If the tumor is localized and successfully removed via surgery before it spreads outside the kidney, the long-term prognosis is exceptionally good. While metastatic (advanced) cases do not currently have a definitive cure, modern treatments are highly effective at managing the disease.
2. What is the survival rate for this type of kidney cancer?
The survival rate relies heavily on the stage at diagnosis. Because early detection methods have improved, the five-year survival rate for Stage I renal cell carcinoma is currently around 90%. For advanced stages, life expectancy has dramatically increased from months to years, thanks to breakthroughs in targeted and immunotherapies.
3. Can renal cell carcinoma be prevented?
While you cannot eliminate the risk entirely, you can take significant steps to protect yourself. Adopting a healthy lifestyle is key: avoiding or quitting smoking, managing your weight, keeping your blood pressure in a healthy range, and avoiding unnecessary exposure to toxic chemicals.
4. Where does renal cell carcinoma usually spread first?
When this cancer progresses and metastasizes (spreads) beyond the kidney, it most commonly travels to the nearby lymph nodes, the lungs, bones, liver, and brain.
5. Why don’t doctors usually perform a biopsy to diagnose kidney cancer?
Unlike many other cancers, inserting a needle into the kidney to extract a tissue sample carries a high risk of causing kidney damage or bleeding. Modern imaging technologies like CT scans and MRIs are incredibly accurate at identifying tumors, so doctors usually rely on these scans and test the tissue only after the mass has been safely removed during surgery.
